Damage Mediated by Dysfunction of Organelles and Cellular Systems: Lysosomes

Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms

Volumn , Issue , 2014, Pages 97-107

  Mari M ^a   Fernandez Checa, J C ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INST D INVESTIGACIONS B   (Spain)

Author keywords

Cathepsin; Cholesterol; GangLiosides; Lipotoxicity; LMP; LSDs; Lysosomal membrane permeabiLization; Lysosomal storage disorders; Lysosome; SphingoLipids

Indexed keywords

EID: 84977804674     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-386456-7.01406-4     Document Type: Chapter

References (54)

1. Ballabio A., Gieselmann V. Lysosomal disorders: from storage to cellular damage. Biochim. Biophys. Acta 2009, 1793:684-696.
2. de Duve C. The lysosome turns fifty. Nat. Cell Biol. 2005, 7:847-849.
3. De Duve C., Pressman B.C., Gianetto R., Wattiaux R., Appelmans F. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-Liver tissue. Biochem. J. 1955, 60:604-617.
4. Futerman A.H., van Meer G. The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 2004, 5:554-565.
5. Kaminskyy V., Zhivotovsky B. Proteases in autophagy. Biochim. Biophys. Acta 2012, 1824:44-50.
6. Kurz T., Terman A., Brunk U.T. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch. Biochem. Biophys. 2007, 462:220-230.
7. Luzio J.P., Pryor P.R., Bright N.A. Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol. 2007, 8:622-632.
8. Pivtoraiko V.N., Stone S.L., Roth K.A., Shacka J.J. Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death. Antioxid. Redox Signal. 2009, 11:481-496.
9. Reiser J., Adair B., Reinheckel T. SpeciaLized roles for cysteine cathepsins in health and disease. J. CLin. Invest. 2010, 120:3421-3431.
10. Repnik U., Stoka V., Turk V., Turk B. Lysosomes and lysosomal cathepsins in cell death. Biochim. Biophys. Acta 2012, 1824:22-33.
11. Saftig P., Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 2009, 10:623-635.
12. Schroder B.A., Wrocklage C., HasiLik A., Saftig P. The proteome of lysosomes. Proteomics 2010, 10:4053-4076.
13. Settembre C., Zoncu R., Medina D.L., Vetrini F., Erdin S., Huynh T., et al. A lysosome-to-nucleus signalLing mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 2012, 31:1095-1108.
14. Turk B., Turk V. Lysosomes as "suicide bags" in cell death: myth or reaLity?. J. Biol. Chem. 2009, 284:21783-21787.
15. Blomgran R., Zheng L., Stendahl O. Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabiLization. J. Leukoc. Biol. 2007, 81:1213-1223.
16. Brix K., Dunkhorst A., Mayer K., Jordans S. Cysteine cathepsins: cellular roadmap to different functions. Biochimie 2008, 90:194-207.
17. Lutgens S.P., Cleutjens K.B., Daemen M.J., Heeneman S. Cathepsin cysteine proteases in cardiovascular disease. FASEB J. 2007, 21:3029-3041.
18. Mohamed M.M., Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 2006, 6:764-775.
19. Reiser J., Adair B., Reinheckel T. SpeciaLized roles for cysteine cathepsins in health and disease. J. CLin. Invest. 2010, 120:3421-3431.
20. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most Likely route. J. Biol. Chem. 2001, 276:3149-3157.
21. Turk B., Turk du S.A., Turk V. Protease signalLing: the cutting edge. EMBO J. 2012, 31:1630-1643.
22. Boya P., Kroemer G. Lysosomal membrane permeabiLization in cell death. Oncogene 2008, 27:6434-6451.
23. Cirman T., Oresic K., Mazovec G.D., Turk V., Reed J.C., Myers R.M., et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-Like lysosomal cathepsins. J. Biol. Chem. 2004, 279:3578-3587.
24. Droga-Mazovec G., Bojic L., PeteLin A., Ivanova S., Romih R., Repnik U., et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J. Biol. Chem. 2008, 283:19140-19150.
25. Edelmann B., Bertsch U., Tchikov V., Winoto-Morbach S., Perrotta C., Jakob M., et al. Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyeLinase in TNF-R1 receptosomes. EMBO J. 2011, 30:379-394.
26. Garcia-Ruiz C., Colell A., Mari M., Morales A., Calvo M., Enrich C., et al. Defective TNF-alpha-mediated hepatocellular apoptosis and Liver damage in acidic sphingomyeLinase knockout mice. J. CLin. Invest. 2003, 111:197-208.
27. Gatt S., Dagan A. Cancer and sphingoLipid storage disease therapy using novel synthetic analogs of sphingoLipids. Chem. Phys. Lipids 2012, 165:462-474.
28. Gault C.R., Obeid L.M., Hannun Y.A. An overview of sphingoLipid metaboLism: from synthesis to breakdown. Adv. Exp. Med. Biol. 2010, 688:1-23.
29. Heinrich M., Wickel M., Schneider-Brachert W., Sandberg C., Gahr J., Schwandner R., et al. Cathepsin D targeted by acid sphingomyeLinase-derived ceramide. EMBO J. 1999, 18:5252-5263.
30. Kagedal K., Zhao M., Svensson I., Brunk U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem. J. 2001, 359:335-343.
31. Li W., Yuan X., Nordgren G., Dalen H., Dubowchik G.M., Firestone R.A., et al. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett. 2000, 470:35-39.
32. Mari M., Colell A., Morales A., Paneda C., Varela-Nieto I., Garcia-Ruiz C., et al. Acidic sphingomyeLinase downregulates the Liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J. CLin. Invest. 2004, 113:895-904.
33. Repnik U., Stoka V., Turk V., Turk B. Lysosomes and lysosomal cathepsins in cell death. Biochim. Biophys. Acta 2012, 1824:22-33.
34. Terman A., Kurz T., Gustafsson B., Brunk U.T. Lysosomal labiLization. IUBMB Life 2006, 58:531-539.
35. Uchimoto T., Nohara H., Kamehara R., Iwamura M., Watanabe N., Kobayashi Y. Mechanism of apoptosis induced by a lysosomotropic agent, l-leucyl-l-leucine methyl ester. Apoptosis 1999, 4:357-362.
36. Almaguel F.G., Liu J.W., Pacheco F.J., De Leon D., Casiano C.A., De Leon M. Lipotoxicity-mediated cell dysfunction and death involve lysosomal membrane permeabiLization and cathepsin L activity. Brain Res. 2010, 1318:133-143.
37. Ibrahim S.H., KohLi R., Gores G.J., et al. Mechanisms of Lipotoxicity in NAFLD and cLinical impLications. J. Pediatr. Gastroenterol. Nutr. 2011, 53:131-140.
38. Schaffer J.E. Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 2003, 14:281-287.
39. Bedia C., Levade T., Codogno P. Regulation of autophagy by sphingoLipids. Anticancer Agents Med Chem. 2011, 11:844-853.
40. Cox T.M., Cachon-Gonzalez M.B. The cellular pathology of lysosomal diseases. J. Pathol. 2012, 226:241-254.
41. d'Azzo A., Tessitore A., Sano R. GangLiosides as apoptotic signals in ER stress response. Cell Death Differ. 2006, 13:404-414.
42. Futerman A.H., van Meer G. The cell biology of lysosomal storage disorders. Nat. Rev. Mol. Cell Biol. 2004, 5:554-565.
43. Ginzburg L., Kacher Y., Futerman A.H. The pathogenesis of glycosphingoLipid storage disorders. Semin. Cell Dev. Biol. 2004, 15:417-431.
44. Hers H.G. alpha-Glucosidase deficiency in generaLized glycogen-storage disease (Pompe's disease). Biochem. J. 1963, 86:11-16.
45. Lachmann R. Treatments for lysosomal storage disorders. Biochem. Soc. Trans. 2010, 38:1465-1468.
46. Lloyd-Evans E., Morgan A.J., He X., Smith D.A., ElLiot-Smith E., Sillence D.J., et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat. Med. 2008, 14:1247-1255.
47. Mari M., Fernandez-Checa J.C. SphingoLipid signalLing and Liver diseases. Liver Int. 2007, 27:440-450.
48. Sorice M., Garofalo T., Misasi R., ManganelLi V., Vona R., Malorni W. GangLioside GD3 as a raft component in cell death regulation. Anticancer Agents Med Chem. 2012, 12:376-382.
49. Vitner E.B., Platt F.M., Futerman A.H. Common and uncommon pathogenic cascades in lysosomal storage diseases. J. Biol. Chem. 2010, 285:20423-20427.
50. Walkley S.U. Pathogenic cascades in lysosomal disease-Why so complex?. J. Inherit. Metab. Dis. 2009, 32:181-189.
51. Woloszynek J.C., Coleman T., Semenkovich C.F., Sands M.S. Lysosomal dysfunction results in altered energy balance. J. Biol. Chem. 2007, 282:35765-35771.
52. Hide and Seek Foundation for lysosomal disease research. http://www.hideandseek.org/Diseases.html.
53. Lysosomal Disease Network. http://www.lysosomaldiseasenetwork.org/.
54. OnLine MendeLian Inheritance in Man. http://www.omim.org.